Navigation Links
A critical moment in the field of lung cancer
Date:3/4/2010

Rapid advances in drug development, genetics and multidisciplinary treatment have brought the field of oncology to a critical moment, says Dr. Rafael Rosell from the Catalan Institute of Oncology in Badalona, Spain, co-chair of the second European Lung Cancer Conference (ELCC), which will be held in Geneva, Switzerland from 28 April to 1 May 2010.

More than 1,500 delegates are expected at the conference, which is a joint initiative of the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC).

"Recognized as the leading force of medical oncology in Europe, ESMO is partnering with key associations to provide the oncology community with the best knowledge in selected areas, including lung cancer," said Dr. Rolf Stahel, Chair of the ESMO Educational Committee.

"The International Association for the Study of Lung Cancer is the world's largest professional organization solely dedicated to reducing the burden of lung cancer and other thoracic malignancies. Educational programs are one way in which we accomplish this goal. We are proud to work jointly with ESMO in Europe to sponsor the largest European meeting on lung cancer," said Dr. Paul Bunn, IASLC Executive Director.

The event program will build on the success of the first European Lung Cancer Conference, which was held in 2008. Cutting-edge data on experimental new drugs, improvements in diagnosis and advances in treatment will be complemented by sessions on important topics presented by the world's leading authorities and debates on controversial topics. Dr. Ala Din Alwan, WHO Assistant Director-General for Non-Communicable Diseases and Mental Health, will address the opening session of the conference.

Media representatives are welcome to register and attend the second ELCC. A fully equipped press room will be available on-site. For those who cannot attend in person, the organizers are happy to provide full
'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. gloStream Presentation to Focus on Microsoft Platform's Critical Role in EHR Development and Patient Information Access and Portability
2. Guardian Offers Critical Illness Insurance Advice
3. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
4. Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
5. Caregivers of ICU patients are collateral damage of critical illness, say Pitt researchers
6. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
7. In Earthquake Aftermath, Response Time is Critical: How MEDEX Global Solutions Protected Clients and Travelers
8. Scientists discover cells critical to childhood leukemia
9. Disclosing sexual abuse is critical
10. Huntington Hospital Uses New Technology to Assist Nurses; Voalte iPhone Application Improves Critical Communication at Point-of-Care
11. Studies Show Doctors Rapidly Forget Critical, Life-Saving Skills such as CPR and Life Support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Family, friends, students, colleagues, mentors and fellow ... LaSalle D. Leffall, on Monday, May 18, with an ... Rounds in the hospital’s Tower Auditorium. Leffall’s younger sister, ... trying to keep the secret. “I’d like to go ... he’ll know something is up,” she said. , After ...
(Date:5/22/2015)... May 22, 2015 According to a new ... generations are equally as likely to worry about what will ... Gen X, 77% Boomers, 69% Silent Generation), which may help ... are scared of aging, particularly Millennials (47%), Gen X’ers (51%), ... Poll in April, 2015 among more than 2,000 U.S. adults ...
(Date:5/22/2015)... Philadelphia, PA (PRWEB) May 22, 2015 According ... as a hub for drug related death, totaling almost 2,500 ... number, as reported by state officials, totals 2,489 deaths stemming ... numbers work out, Pennsylvania loses seven people every day to ... Philadelphia has been singled out as one of the most ...
(Date:5/22/2015)... 2015 sweetFrog Enterprises, LLC. is pleased to ... Jacksonville is now the 16th sweetFrog store located in the ... as #22 on the Inc. 500 list of fastest growing ... worked in East Texas for 20 years and love the ... the Jacksonville, and nearby Palestine, sweetFrog locations. “We are really ...
(Date:5/22/2015)... Ticket Down is a reputable source for ... Eastern Conference Finals Tickets . All seating for the ... the ticket listing. , For the first time in ... of the Eastern Conference. One of the original franchises in ... and downs over the years, but the excitement level for ...
Breaking Medicine News(10 mins):Health News:Colleagues Surprise Dr. LaSalle Leffall with 85th Birthday Celebration 2Health News:New Study Reveals America’s Fear of Aging 2Health News:New Study Reveals America’s Fear of Aging 3Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:sweetFrog Opens New Location in Jacksonville, Texas 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 2Health News:Cheap Lightning vs Rangers NHL Eastern Conference Finals Tickets: Ticket Down Slashes Ticket Prices on New York Rangers vs Tampa Bay Lightning Eastern Conference Playoffs 3
... with Vital Information Missed by Hemoglobin A1c Test to More ... ... WINSTON-SALEM, N.C., July 17 Toyota Tsusho,America, Inc. (New York, NY) ... a new joint venture company, GlycoMark,Inc., dedicated to the discovery and ...
... A person,s heart rate can reveal a lot about how ... Technology academic says. , Economics Associate Professor Uwe Dulleck, from ... necessarily a bad thing, because it was, in fact, a ... , Professor Dulleck is leading the Australian arm of a ...
... help those at risk of obesity or with high ... babies ready to graduate from breast milk or formula ... they receive whole milk, instead of reduced-fat or fat-free ... of Pediatrics (AAP) now advise parents of toddlers who ...
... WeissComm Partners,the largest privately-held PR firm focused ... among the top five Best Midsize,Agencies to Work ... Report., The Holmes Report, which recently named ... approximately 4,700 PR professionals to assess,overall job satisfaction ...
... Assigns PDUFA Date of January 2, 2009 -, ... DDS;,NASDAQ: DDSS) today announced that the response that it ... July 2, 2008, including the,additional analysis of existing data ... complete, Class 2 response. The action date assigned by ...
... Medicine and Molecular Imaging online community to allow medical imaging professionals ... of medical imaging. , ... London, UK (PRWEB) July ... MGT) announces the launch of a focused Nuclear Medicine and ...
Cached Medicine News:Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 2Health News:Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes 3Health News:Decisions under pressure: it's all in the heartbeat 2Health News:Low-Fat Milk OK for Some Toddlers 2Health News:WeissComm Partners Ranks Among Top 5 Best U.S. Midsize PR Agencies to Work For 2Health News:FDA accepts Labopharm's response for once-daily tramadol as complete Class 2 response 2Health News:Medicexchange.com Launches a New Dedicated Nuclear Medicine and Molecular Imaging Community for Medical Imaging Professionals 2
(Date:5/22/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage ... regeneration, today announced that J.J. Finkelstein , chief ... corporate overview at two upcoming investor conferences. ... th Annual Microcap Conference on Thursday May 28, ... at 11:00 am EDT.  A webcast will be available ...
(Date:5/22/2015)... According to a new market research report ... by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), ... - Global Forecast to 2020", published by MarketsandMarkets, the global ... Million by 2020 from $452.36 Million in 2015, growing ... 71 market data Tables and 90 Figures spread through ...
(Date:5/22/2015)... 22, 2015  In a sweeping analysis assessing the ... T1D Exchange researchers conclude that there remains considerable ... across all age groups, but especially for adolescents and ... of diabetes treatment, underscoring the need to address barriers ... can help type 1 patients achieve optimal metabolic control. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... , PRINCETON, N.J. and SAN DIEGO, ... biotechnology company committed to research and product discovery for ... announced results from an in vitro study evaluating TBR-652 ... tenofovir (TDF), etravirine (ETV), and raltegravir (RAL) using the ...
... PARIS and TARRYTOWN, N.Y., Sept. 11 Sanofi-aventis ... Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced the ... Trap) plus gemcitabine versus placebo plus gemcitabine for the first-line ... by an Independent Data Monitoring Committee (IDMC). As part ...
Cached Medicine Technology:Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 2Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 3Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 4Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued 5
... The Brasseler USA™ Battery Packs contain rechargeable ... have a great impact upon battery life. ... necessary. Any deviation from these recommendations will ... sensitive to heat. Any exposure of the ...
... powered system, offers precision with ease ... procedures. The system can be utilized ... oral, maxillofacial, podiatric and otology techniques. ... a high speed drill, low speed ...
Pneumatic oscillating saw, 35k cpm, available with various hose connector styles....
Pneumatic extended oscillating saw, 35k cpm, available with various hose connector styles....
Medicine Products: